These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1679059)

  • 1. Increased glutathione levels in quiescent, serum-stimulated NRK-49F cells are associated not with a response to growth factors but with nutrient repletion.
    Kang YJ; Enger MD
    J Cell Physiol; 1991 Aug; 148(2):197-201. PubMed ID: 1679059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ
    Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation.
    Kang YJ
    Cell Mol Biol Res; 1993; 39(7):675-84. PubMed ID: 8055000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
    Kang YJ; Enger MD
    Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadmium inhibits EGF-induced DNA synthesis but increases cellular glutathione levels in NRK-49F cells.
    Kang YJ; Enger MD
    Toxicology; 1991 Mar; 66(3):325-33. PubMed ID: 2011856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione stimulates A549 cell proliferation in glutamine-deficient culture: the effect of glutamate supplementation.
    Kang YJ; Feng Y; Hatcher EL
    J Cell Physiol; 1994 Dec; 161(3):589-96. PubMed ID: 7962140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of intracellular glutathione content associated with mitogenic stimulation of quiescent fibroblasts.
    Shaw JP; Chou IN
    J Cell Physiol; 1986 Nov; 129(2):193-8. PubMed ID: 3771652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase.
    Messina JP; Lawrence DA
    J Immunol; 1989 Sep; 143(6):1974-81. PubMed ID: 2789253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth-associated modifications of low-molecular-weight thiols and protein sulfhydryls in human bronchial fibroblasts.
    Atzori L; Dypbukt JM; Sundqvist K; Cotgreave I; Edman CC; Moldéus P; Grafström RC
    J Cell Physiol; 1990 Apr; 143(1):165-71. PubMed ID: 2318904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.
    Frischer H; Kennedy EJ; Chigurupati R; Sivarajan M
    J Clin Invest; 1993 Dec; 92(6):2761-7. PubMed ID: 8254030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione depletion in human T lymphocytes: analysis of activation-associated gene expression and the stress response.
    Walsh AC; Michaud SG; Malossi JA; Lawrence DA
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):249-61. PubMed ID: 7645021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
    Xia H; Pinto T; Hu X; Benson PJ; Zaren HA; Gupta V; Singh S
    Cancer Res; 1996 Aug; 56(15):3495-8. PubMed ID: 8758917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous glutathione decreases cellular cadmium uptake and toxicity.
    Kang YJ
    Drug Metab Dispos; 1992; 20(5):714-8. PubMed ID: 1358576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH; Gupta V; Singh SV
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative effects of different types of growth factors on DNA replication, mitosis, and cellular enlargement.
    Zetterberg A; Engström W; Dafgård E
    Cytometry; 1984 Jul; 5(4):368-75. PubMed ID: 6380994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of anchorage-independent cell growth by endothelin in NRK 49F cells.
    Kusuhara M; Yamaguchi K; Kuranami M; Suzaki A; Ishikawa S; Moon H; Adachi I; Hori S; Handa S
    Cancer Res; 1992 Jun; 52(11):3011-4. PubMed ID: 1317255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle.
    Poot M; Teubert H; Rabinovitch PS; Kavanagh TJ
    J Cell Physiol; 1995 Jun; 163(3):555-60. PubMed ID: 7539813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.